The preliminarily investigation of therapeutic effects of mesenchymai stem cells on rat fulminant hepatic failure
10.3760/cma.j.issn.1000-6680.2012.02.007
- VernacularTitle:骨髓间充质干细胞移植对大鼠暴发性肝功能衰竭治疗作用的初步观察
- Author:
Rui ZHOU
;
Yuanping ZHOU
;
Ling ZHENG
;
Zuxiong HUANG
;
Jianrong HUANG
;
Chen PAN
- Publication Type:Journal Article
- Keywords:
Bone marrow transplantation;
Mesenchymal stem cell transplantation;
Flow cytometry;
Liver failure,acute;
Disease models,animal
- From:
Chinese Journal of Infectious Diseases
2012;30(2):85-89
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the therapeutic effects of mesenchymal stem cells (MSC) on rat fulminant hepatic failure (FHF). Methods The rat MSC were separated and purified by adherent culture of whole bone marrow cells. The rat FHF models were established by CCl4 intragastric administration.The rats were divided into experimental group (n=20) and model control group (n=20).And the same dose of saline was administered to rats as normal controls (n=8).Dosage of 1.0 × 106 4',6-diamidino-2-phenylindole (DAPI) labeled MSC were transplanted into rats in experimental group and normal control group through caudal veins,and the same dose of saline was given intravenously in model control group.Part of rats in each group were sacrificed after 7 days and 14 days of injection to evaluate the general condition,survival rate,liver function,tumor necrosis factor (TNF)-α level,liver pathology and MSC homing to the liver between experimental group and model control group.Normal distribution data were compared by independent-sample t test and nonnormal distribution data were analyzed by non-parameter test.ResultsAfter 3 days of injection,the generalcondition of experimental group were better than the model control group. After 7 days of injection,there were 15 and 8 survival rats,the survival rates were statistically different between experimental group and model control group (x2 =4.122,P＜0.05).After 7 days and 14 days of injection,the liver function and TNF-α levels were statistically different between experimental group and model control group (both P ＜0.05),and liver pathology improvement in experimental group was more significant than model control group.DAPI labeled cells increased after transplantation in experimental group, whilefewDAPIlabeledcellswere observedinnormalcontrolgroup.ConclusionsMSC can home to liver of FHF rats after MSC allogeneic transplantation through caudal veins,which can improve liver immunity and liver tissue necroinflammation,and facilitate recovery of liver function.Therefore,it is demonstrated that MSC transplantation has obvious therapeutic effect on rat FHF.
